GTCR’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
GTCR's MRVI Position: Q3 2026 in Review
GTCR held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 20,150,005 shares worth $154M. The position accounts for 3.59% of the portfolio, ranked #3.
GTCR first reported a position in MRVI in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.06B in Q3 2021. 146 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- GTCR held 20,150,005 shares of Maravai LifeSciences worth $154M as of Q3 2026.
- GTCR left its Maravai LifeSciences share count unchanged in Q3 2026.
- Maravai LifeSciences made up 3.59% of GTCR's portfolio in Q3 2026, its #3 holding.
- GTCR first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 24 quarters since.
- GTCR's Maravai LifeSciences position peaked at $1.06B in Q3 2021.
- 146 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on GTCR's 13F filing for Q3 2026, filed 13 Nov 2026.